1Rothermund TM,Peter SM. S-100 in Brain Damage and Neurodegeneration[J]. Microse Res Tech, 2003,60: 614- 620.
2Wunderlich MT, Hanhoff T, Goertler M,et al. Release of brain-type and heart-type fatty acid-hinging proteins in serum after acute ischemic stroke[J]. Neurol, 2005,252 : 718-730.
3Pelsers MM, Hanhoff T. Brain- and heart-type fatty acidbinding proteins in the brain:tissue distribution and clinical utility[J]. Clinical Chemistry,2004,50(9) : 1568-1591.
4Maurice M, Thorsten H, Danielle vander V, et al. Brain and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility [J]. Clinical Chemistry,2004,50(9) :1560-1578.
6Oh SH, Lee JG, Na SJ, et al. Prediction of early clinical seventy and extent of neuronal damage in anterior circulation infarction using the initial serum neuron-specific enolase level[J]. Archives of neurology, 2003,60 : 37-51.
7Tiainen M,Roine RO,Pettila V,et al. serum neuron-specific enolase and sl00B protein in cardiac arrest patients treated with hypothermia [J]. Stroke, 2003,34 (12) : 2881- 2905.
8Wunderlich MT, Ebert AD, Kratz TY, et al. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage[J]. Stoke, 1999,30 : 1190-1215.
9Lee JG, Oh SH, Na SJ, et al. The effect of initial serum neuron-specific enolase level on clinical outcome in acute carotid artery territory infarction[J]. Yonsei Med, 2002, 43(3) :357-369.
10Cunningham RT, Watt M,Winder J, et al. Serum neuron specific enolase as a indicator of stroke volume[J]. Clin Invest, 1996,26 : 298-312.
5Krumholz HM, Lin Z, Keenan PS, et al. Relationship between hospital readmission and mortality rates for patients hospital- ized with acute myocardial infarction, heart failure, or pneu- monia[ J] .JAMA,2013,309(6) :587-593.
